Compare Cigna Corp (CI) vs Nutrien Ltd (NTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Nutrien Ltd — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Nutrien Ltd trades at $67.28 (market cap $31.60B). The key difference: Cigna Corp is far larger — about 2.3× Nutrien Ltd's market cap, and Nutrien Ltd pays the higher dividend (3.32%). Which is the better fit depends on your goals.
| CI | NTR | |
|---|---|---|
Market Cap | $73.56B | $31.60B |
Sector | Health | Basic Materials |
52-Week High | $311.00 | $83.94 |
52-Week Low | $244.41 | $53.64 |
Enterprise Value | $98.27B | $43.40B |
Dividend Yield | 2.24% | 3.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Nutrien Ltd. (NTR) trades at $64.42, down 3.51% over 24 hours, with a bearish technical signal. The stock shows mixed earnings, missing Q2 2026 EPS estimates but beating in Q1. Fundamentals include a P/E of 13.04, net income margin of 8.44%, and a dividend of $0.55 per share. Recent news highlights strong potash sales and cost management, though input cost pressures persist.
The outlook is cautiously optimistic, supported by analyst consensus of $76.67 price target and 60.61% buy ratings. Key opportunities include structural gas advantages and agricultural cycle recovery, while risks involve volatile fertilizer demand and margin compression from higher costs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →
